CVX vs PFE: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Chevron Corporation · Energy
$193.33
-18.2% upside to fair value
Grade D
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
PFE |
| Current Price |
$193.33 |
$26.33 |
| Fair Value Estimate |
$158.09 |
$33.85 |
| Upside to Fair Value |
-18.2%
|
+28.6%
|
| Market Cap |
$385.8B |
$149.8B |
| Forward P/E |
31.3x
|
19.3x
|
| EV / EBITDA |
10.3x
|
12.9x
|
| Price / Sales |
2.1x
|
2.4x
|
| Price / FCF |
23.8x
|
16.5x
|
| Revenue Growth YoY |
-5.3%
|
-1.2%
|
| Gross Margin |
30.4%
|
70.3%
|
| Operating Margin |
9.0%
|
24.7%
|
| Return on Equity |
7.3%
|
8.7%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.19%
|
6.06%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Chevron Corporation operates as a leading integrated oil and gas company with significant upstream and downstream operations. The company benefits from experienced leadership under CEO Mike Wirth, who has over 44 years with Chevron, and maintains a strong market position as the second largest Big Oil major by market cap and net profits. However, Chevron currently trades at a very expensive valuat…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
CVX |
PFE |
| Zone Low |
$118.57 |
$25.39 |
| Zone High |
$134.38 |
$28.77 |
| In Buy Zone? |
No
|
Yes
|